肺功能和症状在异形性肺纤维化治疗高流鼻治疗1年
Francesca Simioli1, Anna Annunziata1, Maurizia Lanza1
1Department of Respiratory Pathophysiology and Rehabilitation, Azienda Ospedaliera di Rilievo Nazionale dei Colli, Monaldi Hospital, Naples, Italy.
Respiration; international review of thoracic diseases
|March 30, 2025
概括
高流量鼻腔疗法 (HFNT) 在异常性肺纤维化 (IPF) 患者的慢性咳中提供了显著的缓解. 虽然它没有改善肺功能,但HFNT为IPF的症状管理提供了有价值的非药物选择.
科学领域:
- 肺部病理学 肺部病理学
- 呼吸系统医学 呼吸系统医学
- 关键的护理关键的护理
背景情况:
- 异形性肺纤维化 (IPF) 是一种进展性肺部疾病,导致呼吸衰竭.
- 与IPF相关的呼吸衰竭目前的治疗方法包括急性情况下的高流鼻疗法 (HFNT).
- 在IPF中,慢性咳往往对标准治疗不耐药,除了阿片类药物之外的选择有限.
研究的目的:
- 研究长期高流量鼻腔治疗 (HFNT) 在治疗异常性肺纤维化 (IPF) 的有效性和安全性.
- 评估慢性HFNT对IPF患者肺功能和关键症状的影响.
- 评估HFNT作为常规氧气疗法 (COT) 的替代方案,用于IPF慢性症状管理.
主要方法:
- 一个单中心病例控制研究,涉及35名被诊断患有IPF的成年患者.
- 患者接受标准治疗,包括抗纤维素药物和常规氧气疗法 (COT).
- 18名患者在标准护理之外,还接受了12个月的HFNT治疗.
主要成果:
- 与COT相比,长期的HFNT没有显著改变肺功能,强迫生命能力 (FVC) 或一氧化碳 (DLCO) 扩散能力 (DLCO) 没有显著差异.
- 没有观察到对呼吸障碍的显著影响,HFNT和COT组之间的博格尺度得分相似.
- 与传统氧气疗法相比,HFNT显示慢性咳得分显著降低 (p < 0.0001).
结论:
- 长期的HFNT有效地显著减少了IPF患者的慢性咳.
- 在IPF患者中,HFNT不会显著影响肺功能参数,如FVC和DLCO.
- 慢性HFNT是一种有希望的非药物治疗方法,用于治疗IPF患者的耐火性慢性咳.
相关概念视频
Pulmonary Cycle: Exhalation
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
Acute Respiratory Failure-V
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...


